【艾昆纬IQVIA】2024年数字健康趋势报告对研究和患者诊治的影响_93页_2mb

Digital Health Trends 2024: Implications for Research and Patient Care

Core Content

The Digital Health Trends 2024 report from the IQVIA Institute for Human Data Science outlines the evolving landscape of digital health, highlighting both challenges and opportunities across various segments. It provides insights into the current state of digital health technologies, their applications in patient care, and the implications for research and healthcare systems.

Main Trends

1. Market Challenges and Resilience

• Digital health companies have faced significant financial and operational challenges in recent years, including reduced funding and struggles with user growth.
• Despite these challenges, innovation remains strong, with new digital health products entering a more mature global market.
• The report notes that the number of consumer health apps has stabilized, with over 300,000 currently available, though many are no longer actively marketed.

2. Digital Therapeutics (DTx)

• Over 360 software-based therapeutic tools are now available, with some accessible to consumers and others used by providers.
• Digital therapeutics are increasingly being used for chronic disease management, mental health, and visual and dermatologic conditions.
• Regulatory and reimbursement pathways are expanding, with 140 DTx products granted market access through national approvals.
• Digital care programs are becoming the primary channel for DTx use, with over 180 programs available globally.

3. Sensor-Based Digital Measures

• Wearable sensors and digital biomarkers are enabling more nuanced and continuous health monitoring.
• These tools are being used in clinical trials to capture high-quality data and improve trial efficiency.
• The FDA and EMA have begun to approve digital endpoints, including those based on wearables, for use in clinical studies.
• AI and machine learning are playing a critical role in analyzing sensor data for disease detection and management.

4. Digital Diagnostics and Health Assessment Tools

• Software-based devices that integrate with biosensors are now used for disease risk screening, diagnosis, and monitoring.
• Over 100 digital diagnostics are commercially available, covering conditions such as autism, sleep apnea, and sepsis.
• AI/ML enabled tools are increasingly used in both consumer and clinical settings to improve diagnostic accuracy and access.

5. Uptake and Use of Digital Health Technologies

• Digital health tools are being increasingly adopted by patients and health systems to close care gaps and improve outcomes.
• Remote patient monitoring tools, such as wearables and symptom-tracking apps, are becoming integral to clinical care and research.
• In the U.S., provider billing for remote monitoring has increased five-fold in three years, and new codes for remote therapeutic monitoring have nearly quadrupled.
• Digital care solutions are gaining traction, particularly in employer benefit programs and for chronic disease management.

6. Investment and Innovation Cycle

• Digital health investment has declined since 2021, but there is a sign of recovery in Q2 2024.
• The report highlights the importance of understanding market pitfalls and developing next-generation products that are more commercially viable.
• Companies are shifting to alternative business models with clearer revenue prospects and lower regulatory barriers.

Key Information

• Regulatory and Reimbursement Pathways: These are expanding, especially for digital therapeutics and diagnostics, which are increasingly being integrated into clinical practice.
• Consumer Access: Some high-quality health apps are no longer available to consumers due to shifting to prescription-only models, limiting access.
• Global Adoption: Germany leads in DTx approvals and reimbursement, while the U.S. faces challenges with commercialization and reimbursement.
• AI Integration: AI is central to the development and application of digital health tools, from diagnostics to patient monitoring and care.
• Healthcare Provider Focus: There is growing interest in provider-facing solutions, including clinical decision support tools and digital platforms that enhance care delivery.

Conclusion

The digital health landscape is evolving, with a shift from consumer-focused apps to more integrated, evidence-based solutions. While challenges persist, the expansion of regulatory and reimbursement pathways, the integration of AI and sensor technologies, and the development of sustainable business models are driving the field forward. The report emphasizes the importance of clinical evidence in improving adoption and commercial success, and anticipates further shifts in business strategies and global policy in the coming year.